Allurion Technologies (ALUR) Income towards Parent Company (2022 - 2026)
Allurion Technologies (ALUR) posted Income towards Parent Company of -$6.1 million for Q1 2026, up 2.96% on a QoQ basis from -$6.3 million in Q4 2025, and down 306.06% year-over-year from $3.0 million in Q1 2025.
Allurion Technologies (ALUR) Income towards Parent Company (2022 - 2026) Analysis & Trends
Allurion Technologies' Income towards Parent Company history runs 5 years deep, the most recent figure standing at -$6.1 million for Q1 2026.
- Quarterly Income towards Parent Company fell 306.06% year-over-year to -$6.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$33.6 million (down 206.61% YoY) and the FY2025 annual result came in at -$29.0 million, down 291.59% from the prior year.
- Income towards Parent Company was -$6.1 million for Q1 2026 at Allurion Technologies, up from -$6.3 million in the prior quarter.
- Across five years, Income towards Parent Company topped out at $8.7 million in Q3 2024 and bottomed at -$22.0 million in Q2 2023.
- A 5-year average of -$9.8 million and a median of -$9.6 million in 2024 frame the typical range for Income towards Parent Company.
- Annual changes were most pronounced in 2023 — Income towards Parent Company plunged 306.96% — and 2024, when it jumped 140.25%.
- Allurion Technologies' Income towards Parent Company stood at -$13.0 million in 2022, then sank by 64.36% to -$21.4 million in 2023, then jumped by 54.17% to -$9.8 million in 2024, then jumped by 35.93% to -$6.3 million in 2025, then climbed by 2.96% to -$6.1 million in 2026.
- Business Quant data shows ALUR's Income towards Parent Company at -$6.1 million in Q1 2026, -$6.3 million in Q4 2025, and -$11.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Allurion Technologies | 74.67 Mn | 69.62 Mn | 1.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.10 Mn |
| Dec 31, 2025 | -6.28 Mn |
| Sep 30, 2025 | -11.88 Mn |
| Jun 30, 2025 | -9.34 Mn |
| Mar 31, 2025 | -1.50 Mn |
| Dec 31, 2024 | -9.80 Mn |
| Sep 30, 2024 | 8.71 Mn |
| Jun 30, 2024 | -8.36 Mn |
| Mar 31, 2024 | 1.97 Mn |
| Dec 31, 2023 | -21.39 Mn |
| Sep 30, 2023 | -21.63 Mn |
| Jun 30, 2023 | -22.00 Mn |
| Mar 31, 2023 | -17.80 Mn |
| Dec 31, 2022 | -13.01 Mn |
| Sep 30, 2022 | -13.57 Mn |
| Jun 30, 2022 | -5.41 Mn |